Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01368900 · ClinicalTrials.gov registry record · NA
Reducing Wrinkles Around the Eyes Using the Ulthera® System
A NA study of Periorbital Wrinkles, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 2
- Study locations
NCT01368900: Completed NA study of Periorbital Wrinkles, sponsored by Ulthera.
NCT01368900 is a NA study of Periorbital Wrinkles that has completed, run by Ulthera. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01368900, a NA study of Periorbital Wrinkles, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this prospective, multi-center, single treatment study is to evaluate the clinical outcomes associated with the non-invasive treatment to reduce wrinkles around the eyes utilizing the Ulthera® System to deliver focused ultrasound energy below the surface of the skin.
Primary Outcome
Improvement in periorbital skin laxity and rhytids as determined by masked assessor review of photographs at 90days post-treatment compared to baseline.
Conditions Studied
Interventions
- DEVICE Ulthera® System treatment
Study Locations (2)
Maryland
- MD Laser Skin & Vein Institute - Hunt Valley
Tennessee
- The Nashville Centre for Laser and Facial Surgery - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT01368900 record still lists
NCT01368900 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Periorbital Wrinkles appearing as the primary indexed condition, and to 1 intervention - of which Ulthera® System treatment is the first listed.
NCT01368900 reports a single indexed study location in Maryland, Tennessee.
Frequently Asked Questions
What is clinical trial NCT01368900 about?
NCT01368900 is a clinical study titled "Reducing Wrinkles Around the Eyes Using the Ulthera® System". The purpose of this prospective, multi-center, single treatment study is to evaluate the clinical outcomes associated with the non-invasive treatment to reduce wrinkles around the eyes utilizing the Ulthera® System to deliver focused ultrasound energy below the surface of the skin.
What is the current status of trial NCT01368900?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2011-03. Estimated completion is 2012-01.
What conditions does trial NCT01368900 study?
This clinical trial studies the following conditions: Periorbital Wrinkles.
What interventions are being tested in trial NCT01368900?
The interventions under investigation include: Ulthera® System treatment (DEVICE).
Who is sponsoring clinical trial NCT01368900?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01368900 being conducted?
This trial has 2 study locations across Maryland, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01368900's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia